Overview

Safety, Tolerability and Pharmacokinetics of Efavirenz in HIV-Infected Children

Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to find the dose of Efavirenz for young children. The safety and how the medication is tolerated will also be studied.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Bristol-Myers Squibb
Treatments:
Didanosine
Efavirenz
Emtricitabine